36 下列 phosphate-binding agents 中,何者不建議用於末期腎病患者?
(A) Calcium acetate
(B) Calcium carbonate
(C) Calcium citrate
(D) Sevelamer HCl
答案:登入後查看
統計: A(36), B(42), C(247), D(60), E(0) #413055
統計: A(36), B(42), C(247), D(60), E(0) #413055
詳解 (共 2 筆)
#1430300
檸檬酸鈣(calcium citrate)要避免,因為會促進鋁
的吸收。
26
0
#878455
Sevelamer is a phosphate binding drug used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer HCl (Renagel) 在腸胃道內能與磷結合,但又不影響血清鈣濃度,因此常被用於治療末期腎病患者高血磷
12
0